Dr. Scheff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
520 E 70th Street
Starr 341
New York, NY 10021Phone+1 646-962-2066Fax+1 646-962-1603
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1992 - 1995
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1988 - 1991
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1988
Certifications & Licensure
- CA State Medical License 1991 - Present
- NY State Medical License 1992 - 2026
- NJ State Medical License 2004 - 2007
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab) Start of enrollment: 2009 Jul 01
- Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma Start of enrollment: 2011 Aug 01
- Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA Start of enrollment: 2009 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Giving information strategically and transparently: A pilot trial of the Oncolo-GIST intervention to promote patients' prognostic understanding.Holly G Prigerson, David Russell, Sophia E Kakarala, Heather M Derry-Vick, Manish A Shah
Cancer Medicine. 2023-09-01 - 13 citationsLung Cancer Stage Shift as a Result of COVID-19 Lockdowns in New York City, a Brief Report.Nathan Mynard, Ashish Saxena, Alexandra Mavracick, Jeffrey L. Port, Benjamin Lee
Clinical Lung Cancer. 2021-08-29 - 165 citationsNeoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trialNasser K. Altorki, Timothy E. McGraw, Alain C. Borczuk, Ashish Saxena, Jeffrey L. Port
The Lancet. Oncology. 2021-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: